Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
about
Regulation of TAZ in cancerMechanisms of Hippo pathway regulationCDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activityCysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ.The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
P2860
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
@en
type
label
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
@en
prefLabel
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
@en
P2860
P356
P1433
P1476
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
@en
P2093
Xiaolong Yang
Yulei Zhao
P2860
P304
21906-21917
P356
10.18632/ONCOTARGET.4259
P407
P577
2015-06-08T00:00:00Z